NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Top Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+2 more ↓
69%
Finnrick rating
#297 of 457 ranked vendors
36 of 48 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Top Peptide's purity-focus record is strongest on Retatrutide and GHK-Cu, where repeated clean identity/purity results outweigh fill swings and weak batch traceability. Tirzepatide is more mixed after clustered purity misses before later passes, while BPC-157 remains the thinnest and most volatile signal despite an improved retest.

methodology →
vendor intelligence report
Vendor Intelligence Report: Top Peptide

Corporate records, a separate operator email domain, and a public COA tie the storefront to a broader YH/YiHang trail while stopping short of common-ownership proof. The report also documents exposed site internals, COA gaps, lookalike domains, and direct-contact payment limits.

28 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
-
89%
5
2
Retatrutide
$0.87
85%
13
3
Tirzepatide
$0.50
80%
19
5
BPC-157
-
49%
4
7
hCG
-
-
0
9
NAD+
-
-
0
10
TB-500
-
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Nov 2025: 77%25 Nov 2025: 76%17 Dec 2025: 77%17 Dec 2025: 77%17 Dec 2025: 78%7 Jan 2026: 78%7 Jan 2026: 79%15 Jan 2026: 75%19 Jan 2026: 65%19 Jan 2026: 66%19 Jan 2026: 66%19 Jan 2026: 66%19 Jan 2026: 67%22 Jan 2026: 63%22 Jan 2026: 63%22 Jan 2026: 63%4 Feb 2026: 63%11 Feb 2026: 64%20 Feb 2026: 63%20 Feb 2026: 63%20 Feb 2026: 64%22 Feb 2026: 64%4 Mar 2026: 64%18 Mar 2026: 64%18 Mar 2026: 65%20 Mar 2026: 64%20 Mar 2026: 64%23 Apr 2026: 65%23 Apr 2026: 65%28 Apr 2026: 65%13 May 2026: 66%12 Jun 2026: 66%12 Jun 2026: 66%16 Jun 2026: 66%17 Jun 2026: 69%22 Jun 2026: 69%12 Aug 2026: 69%12 Aug 2026: 70%12 Aug 2026: 70%13 Aug 2026: 69%7 Oct 2026: current 69%77%64%69%Nov 25Oct 26
Free peptide testing

Ordered peptides from Top Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Top Peptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
13 Aug 2026
Fail
Retatrutide
lab nameView COA
12 Aug 2026
Pass
Retatrutide
lab nameView COA
12 Aug 2026
Pass
Tirzepatide
lab nameView COA
12 Aug 2026
Pass
Tesamorelin
lab nameView COA
22 Jun 2026
Pass
Retatrutide
lab nameView COA
17 Jun 2026
Fail
Tesamorelin
lab nameView COA
16 Jun 2026
Pass
Retatrutide
lab nameView COA
12 Jun 2026
Pass
Tirzepatide
lab nameView COA
12 Jun 2026
Pass
Retatrutide
lab nameView COA
13 May 2026
Pass
BPC-157
lab nameView COA
1-10 of 48

About Top Peptide test results from Finnrick

Top Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Top Peptide peptides in this dataset are BPC-157 (4 tests), GHK-Cu (5 tests) and Retatrutide (13 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Top Peptide? Mail in a sample (US only) and let us test it.

Test my supply